As a company, we studied our competitive position and tested where we were really weak.

There were some unforeseen things like a lot of communicating between the company and manufacturer. It gave us a broader view of how business is run. There were bumps. It wasn't a smooth ride. We had to go back and correct things.

It certainly raises a lot of serious questions, with a pharmaceutical company involved in financing the development of a Medicaid (reform plan).

If you look at what we are doing in Green Bay, we are trying to get positioned to be long-term competitive. We are well on our way.

One of the nice things about tissue is we are not losing market share. We are No. 1 in our industry and we intend to stay there.

We are not backing off. We are putting money in here. We are putting in seven brand new pieces of converting equipment. There will be more.